Get Started

IMTX

NASD Immatics N.V.
Oct 30, 2026 · 9:23 AM ET LAST TRADE Market Closed

$7.06 ↓ -0.25 (-3.42%) Trading Down from the previous close of $7.31

YTD change
-32.76%
vs 20-day SMA
-3.39%
vs 200-day SMA
-26.48%

Price ranges

Previous day
$7.20 $7.52
open $7.35 close $7.31
-$0.04 (-0.54%)
Today
$0.00 $0.00
$7.06
Past week
$7.00 $7.73
from $7.54 now $7.06
-$0.48 (-6.37%)
Past month
$6.65 $8.57
from $8.44 now $7.06
-$1.38 (-16.35%)
This year
$6.65 $11.94
from $10.50 now $7.06
-$3.44 (-32.76%)

Price & Performance

-3.68 (-33.48%) / 6M

$6.34$8.23$10.12$12.01Apr 30Jul 31Oct 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 61.7% away from all-time highs of $18.42
  • IMTX is down 33% since the beginning of the year
  • IMTX is down 32% over the past 12 months
  • IMTX is down 16% over the past 1 month
  • 3% of all IMTX investors are betting against IMTX

IMTX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -29.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.532772
Earnings momentum -5.8% Quarterly EPS growth
Quarterly change -5.8%

Valuation

P/E ratio N/A
Enterprise value $566.1M
Beta 1.87

Balance sheet & scale

IncomeN/A
Revenue$47.5M
Cash$449.7M
Debt$16.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $1.1B

Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $35.00 +0.69%
ARGX argenx SE Sponsored ADR $897.85 +0.68%
ONC BeOne Medicines Ltd. Sponsored ADR $371.56 -0.48%
WXIBF Wuxi Biologics (Cayman) Inc. $5.90 +9.06%
INCY Incyte Corporation $116.80 -0.06%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.